Display options
Share it on

Oncol Lett. 2016 Apr;11(4):2725-2732. doi: 10.3892/ol.2016.4287. Epub 2016 Mar 01.

Establishment of a colorectal cancer nude mouse visualization model of HIF-1α overexpression.

Oncology letters

Zhe Li, Jiye Wang, Tianbao Zhou, Xiaolei Ye

Affiliations

  1. Department of Thyroid and Breast Surgery, The Shanghai Tenth People's Hospital, Tong Ji University, Shanghai 200072, P.R. China.
  2. Department of Criminal Science and Technology, Zhejiang Police College, Hangzhou, Zhejiang 310053, P.R. China.
  3. Hepatobiliary Surgery Centre, The Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, P.R. China.
  4. Division of Drugs and Pharamcology, Ningbo Institute of Medical Sciences, Ningbo, Zhejiang 315020, P.R. China.

PMID: 27073543 PMCID: PMC4812287 DOI: 10.3892/ol.2016.4287

Abstract

The aim of the present study was to establish a model of tumor cell growth and visualize HIF-1α overexpression in a nude mouse xenograft model of colorectal cancer (CRC). In the study, HIF-1α lentiviral vector and helper plasmid were co-transfected into 293T packaging cells using a liposome method, and the virus was collected following transfection and used to infect CRC SW480, SW620, LoVo and HCT116 cells. Puromycin was used for the selection and large-scale amplification of the stable HIF-1α expression of green fluorescent protein (GFP)-positive cells. HIF-1α-expressing cells were injected intraperitoneally into a nude mouse xenograft model, and resulting tumor nodules was separated and confirmed using an inverted fluorescence microscope. The results demonstrated that HIF-1α was not expressed in CRC cells in normoxic conditions. When treated with CoCl

Keywords: HIF-1α; colorectal cancer; green fluorescent protein; lenti virus; stable transfection; xenograft model

References

  1. Gut Liver. 2009 Jun;3(2):88-94 - PubMed
  2. J Cell Mol Med. 2009 Sep;13(9A):2780-6 - PubMed
  3. J Biomed Sci. 2012 Dec 14;19:102 - PubMed
  4. Biochim Biophys Acta. 2005 Sep 10;1745(2):187-95 - PubMed
  5. Int J Oncol. 2014 Jun;44(6):2077-84 - PubMed
  6. CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17 - PubMed
  7. J Gene Med. 2013 Feb;15(2):78-82 - PubMed
  8. Mol Biotechnol. 2007 Jul;36(3):184-204 - PubMed
  9. BMC Cancer. 2009 Dec 10;9:432 - PubMed
  10. Biotechniques. 2003 Nov;35(5):1022-6, 1028-30 - PubMed
  11. Cancer Res. 1999 Nov 15;59(22):5830-5 - PubMed
  12. Cancer Res. 2005 Apr 15;65(8):3299-306 - PubMed
  13. EMBO J. 1998 Jun 1;17(11):3005-15 - PubMed
  14. Oncol Lett. 2013 Mar;5(3):911-916 - PubMed
  15. Free Radic Res. 2007 Apr;41(4):391-401 - PubMed
  16. Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1109-18 - PubMed
  17. Clin Cancer Res. 2014 Apr 15;20(8):2159-68 - PubMed
  18. Am J Pathol. 2000 Aug;157(2):411-21 - PubMed
  19. J Surg Res. 2013 Jun 1;182(1):75-84 - PubMed
  20. Curr Gene Ther. 2008 Dec;8(6):419-29 - PubMed
  21. J Cereb Blood Flow Metab. 2004 Feb;24(2):245-58 - PubMed
  22. J Exp Clin Cancer Res. 2007 Dec;26(4):515-9 - PubMed
  23. Int J Med Sci. 2011 Jan 09;8(1):74-83 - PubMed

Publication Types